Antengene Announces the IND Approval for Eltanexor in Patients with Advanced Solid Tumors in Mainland China ...Middle East

PR Newswire - News
Antengene Announces the IND Approval for Eltanexor in Patients with Advanced Solid Tumors in Mainland China
SHANGHAI and HONG KONG, May 13, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology...

Hence then, the article about antengene announces the ind approval for eltanexor in patients with advanced solid tumors in mainland china was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Antengene Announces the IND Approval for Eltanexor in Patients with Advanced Solid Tumors in Mainland China )

Apple Storegoogle play

Last updated :

Also on site :